Cubist Systematic Strategies, LLC Beyond Spring Inc. Transaction History

Cubist Systematic Strategies, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.13 - $2.66 $18,937 - $44,578	-16,759 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.68 - $5.01 $147,033 - $438,475	-87,520 Reduced 83.93%	16,759 $37,000
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $302,139 - $1.27 Million	75,159 Added 258.1%	104,279 $472,000
Q3 2021 Nov 15, 2021	BUY	$9.26 - $31.31 $269,651 - $911,747	29,120 New	29,120 $459,000
Q1 2021 May 17, 2021	SELL	$10.61 - $15.77 $8,328 - $12,379	-785 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$10.21 - $17.31 $8,014 - $13,588	785 New	785 $10,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $93.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.